Norcodeine
From Wikipedia, the free encyclopedia
|
Norcodeine
|
|
| Systematic (IUPAC) name | |
| 3-methoxy-6α-hydroxy-4,5α-epoxy-7,8-didehydromorphinan | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C17H19NO3 |
| Mol. mass | 285.337 g/mol |
| Synonyms | Norcodeine |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Norcodeine is an opiate analogue that is the N-demethylated derivative of codeine.
Norcodeine has relatively little opioid activity in its own right,[1] but is formed as a metabolite of codeine following ingestion.[2]
[edit] References
- ^ Fraser HF, Isbell H, Van Horn GD. Human pharmacology and addiction liability of norcodeine. Journal of Pharmacology and Experimental Therapeutics. 1960 Jun;129:172-7. PMID 13824628
- ^ Posey BL, Kimble SN. High-performance liquid chromatographic study of codeine, norcodeine, and morphine as indicators of codeine ingestion. Journal of Analytical Toxicology. 1984 Mar-Apr;8(2):68-74. PMID 6716978.

